This case, and the apparent impunity that companies such as Pfizer appear to enjoy, serve as evidence that the system of oversight for Pharma in the UK is hopelessly outdated and that the regulatory authorities are risibly ill-equipped to keep powerful, hugely well-resourced corporate groups in check. The regulatory system for Big Pharma is not fit for purpose; so it is time for a rethink.
One does not have to agree with all of the points made by the MPs, and one does not have to dispute the fact that the vaccine rollout saved lives, to understand that questions raised by elected politicians in this debate – around the scale of adverse events, potential breaches of medical ethics and regulatory capture – are serious.
It is dangerously naive to dismiss this spike in vaccine hesitancy as the deluded actions of an indoctrinated minority of crackpots who must be brought to their senses. Denouncing parents who raise reasonable questions and challenges about risk/benefit for their children as heretic anti-vaxxers, as the public health machine in the US and UK has done repeatedly, is proving equally self-defeating.
Brownstone Institute is a 501(c)(3) Nonprofit registered in the US under EIN: 87-1368060
BROWNSTONE INSTITUTE
2028 E BEN WHITE BLVD, #240-3088
AUSTIN, TX 78741
+1-469-842-8976
—
WEST HARTFORD, CT
Published under a Creative Commons Attribution 4.0 International License
For reprints, please set the canonical link back to the original Brownstone article
en
de
da
sv
pl
pt
es
it
nl
fr
ro
iw
ja
ru
hy
hi
ar
sw
cn
